Odyssean LLC’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.83M Buy
50,732
+19,080
+60% +$1.03M 0.33% 136
2026
Q2
$1.74M Buy
31,652
+16,398
+107% +$671K 0.28% 137
2026
Q1
$507K Sell
15,254
-511
-3% -$15.2K 0.19% 196
2025
Q4
$470K Buy
+15,765
New +$515K 0.34% 163

Other funds holding TGTX

Odyssean LLC's TGTX Position: Q3 2026 in Review

Odyssean LLC increased its TG Therapeutics (TGTX) stake by 60% in Q3 2026, buying an estimated $1.03M and bringing the position to 50,732 shares worth $2.83M. The position accounts for 0.33% of the portfolio, ranked #136.

Odyssean LLC first reported a position in TGTX in Q4 2025 and has held it in 4 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Odyssean LLC held 50,732 shares of TG Therapeutics worth $2.83M as of Q3 2026.
  • Odyssean LLC bought 19,080 TG Therapeutics shares in Q3 2026, an estimated $1.03M.
  • TG Therapeutics made up 0.33% of Odyssean LLC's portfolio in Q3 2026, its #136 holding.
  • Odyssean LLC first reported a position in TG Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.